Andrew R Haas - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Andrew R Haas

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

Nature|September 3, 2011

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humansCaroline J Breitbach, James Burke, Derek Jonker, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026

Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancersJulie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023

Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cellsAndrew R Haas, Ryan J Golden, Leslie A Litzky, et al.

Pageof 8

Search research articles

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

Nature|September 3, 2011

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humansCaroline J Breitbach, James Burke, Derek Jonker, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026

Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancersJulie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2023

Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cellsAndrew R Haas, Ryan J Golden, Leslie A Litzky, et al.

Pageof 8